维瑞塞尔
VCEL
40.13
-0.89
-2.17%
维瑞塞尔
US · VCEL
#2759 按市值排名
上市于 1970
40.13
-0.89
-2.17%
实时 - 追踪5344个代码 - 心跳于176秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 机构持股总比例上升了0.7个百分点。
机构持股
- 机构持股比例
- 111.57% +0.70pp
- 机构数量
- 383
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund93.54%
Hedge Fund9.95%
Public Company4.00%
Private Company1.27%
Insurance Company1.26%
Individual/Insider1.19%
Government Pension Fund1.19%
Sovereign Wealth Fund0.19%
Family Office/Trust0.12%
主要股东 截至 2026-06-30
BlackRock
15.80% · 8.09M 股
State Street Global Advisors
6.43% · 3.29M 股
Congress Asset Management Company, LLP
5.70% · 2.92M 股
Vanguard Capital Management, LLC
5.12% · 2.62M 股
Conestoga Capital Advisors, LLC
4.07% · 2.08M 股
William Blair Investment Management, LLC
3.89% · 1.99M 股
BNPP Asset Management Holding
3.20% · 1.64M 股
GW&K Investment Management, LLC
3.03% · 1.55M 股
Soleus Capital Management, L.P.
2.85% · 1.46M 股
Geode Capital Management, LLC
2.62% · 1.34M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 24次买入 · 26次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Dominick Colangelo | Chief Executive Officer | 0.61% |
| Jonathan Hopper | Chief Medical Officer | 0.15% |
| Alan Rubino | Independent Director | 0.13% |
| Heidi Hagen | Independent Director | 0.07% |
| Robert Zerbe | Independent Chairperson | 0.06% |
| Paul Wotton | Independent Director | 0.04% |
| Kevin McLaughlin | Independent Director | 0.04% |
| Michael Halpin | Chief Operating Officer | 0.03% |
| Joseph Mara | Chief Financial Officer | 0.03% |
| Lisa Wright | Independent Director | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-11 | Kevin McLaughlin | Independent Director | Derivative Exercise and Sale | -7,000 | $13.05–44.53 |
| 2026-08-02 | Michael Halpin | Chief Operating Officer | Derivative Exercise and Sale | -10,000 | $16.66–46.84 |
| 2026-07-29 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Derivative Exercise and Sale | -4,500 | $29.82–48.90 |
| 2026-06-25 | Jonathan Hopper | Chief Medical Officer | Derivative Exercise and Sale | -10,000 | $29.82–45.00 |
| 2026-06-25 | Sean Flynn | Senior Vice President | Derivative Exercise and Sale | -15,000 | $16.25–45.64 |
| 2026-06-25 | Joseph Mara | Chief Financial Officer | Automatic Disposition | -5,000 | $44.75 |
| 2026-06-25 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Automatic Disposition | -232 | $44.90 |
| 2026-06-25 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Derivative Exercise and Sale | -2,500 | $29.82–44.90 |
| 2026-06-17 | Michael Halpin | Chief Operating Officer | Derivative Exercise and Sale | -10,000 | $16.66–40.24 |
| 2026-06-17 | Sean Flynn | Senior Vice President | Derivative Exercise and Sale | -15,000 | $16.25–40.21 |
| 2026-06-01 | Jonathan Hopper | Chief Medical Officer | Derivative Exercise and Sale | -4,375 | $16.66–35.00 |
| 2026-05-12 | Kevin McLaughlin | Independent Director | Derivative Exercise and Sale | -7,000 | $2.63–32.83 |
| 2026-05-12 | Kevin McLaughlin | Independent Director | Other Derivative Acquisition | +7,000 | $2.63–13.05 |
| 2026-05-10 | Paul Wotton | Independent Director | Open Market Disposition | -10,000 | $32.64–33.05 |
| 2026-05-06 | Joseph Mara | Chief Financial Officer | Automatic Disposition | -5,000 | $40.50 |
| 2026-05-06 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Automatic Disposition | -4,855 | $38.00–40.50 |
| 2026-05-06 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Intent to Sell (Form 144) | -1,422 | $40.50 |
| 2026-05-05 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Intent to Sell (Form 144) | -3,433 | $38.00 |
| 2026-04-28 | Kevin McLaughlin | Independent Director | Other Derivative Acquisition | +3,200 | -- |
| 2026-04-28 | Kevin McLaughlin | Independent Director | Other Derivative Acquisition | +8,000 | $33.43 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
维瑞塞尔 讨论区 0 条评论